The efficacy of first-line intravesical chemotherapy for non-muscle-invasive bladder cancer has been tested in the neoadjuvant and chemoresection settings. However, the data available are highly heterogeneous and further high-quality studies are needed before its use can be embraced in either setting.
European urology. 2023 Mar 18 [Epub ahead of print]
Louis Lenfant, Ugo Pinar, Morgan Rouprêt, Thomas Seisen
Sorbonne University, GRC 5, Predictive Onco-urology, Department of Urology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France. Electronic address: ., Sorbonne University, GRC 5, Predictive Onco-urology, Department of Urology, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.